Detailed View
HRMY - Harmony Biosciences Holdings, I
Latest filing: 2026-09-30 | Reporting: gaap
Market Cap
2,004,205,440
Adj EBIT (TTM)
257,334,000
Enterprise Value
1,382,171,440
Last Price
34.41
Earnings Yield
18.62%
Return on Capital
22.67%
Capital
1,135,168,000
1Y Price Chart
Last Price: $34.41
1Y Change: 17.34%
As of 2026-11-04 | 1Y Change: 17.34%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-09-30 | 10-Q | 2026 | 268,917,000 | 54,197,000 |
| 2026-06-30 | 10-Q | 2026 | 261,280,000 | 89,316,000 |
| 2026-03-31 | 10-Q | 2026 | 215,387,000 | 37,291,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 243,776,000 | 38,557,000 |
| 2025-09-30 | 10-Q | 2025 | 239,455,000 | 65,487,000 |
| 2025-06-30 | 10-Q | 2025 | 200,489,000 | 48,180,000 |
| 2025-03-31 | 10-Q | 2025 | 184,733,000 | 56,245,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 201,267,000 | 55,727,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.